GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kenvue Inc (NYSE:KVUE) » Definitions » Cash Conversion Cycle

Kenvue (Kenvue) Cash Conversion Cycle : 12.15 (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Kenvue Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Kenvue's Days Sales Outstanding for the three months ended in Mar. 2024 was 49.6.
Kenvue's Days Inventory for the three months ended in Mar. 2024 was 103.15.
Kenvue's Days Payable for the three months ended in Mar. 2024 was 140.6.
Therefore, Kenvue's Cash Conversion Cycle (CCC) for the three months ended in Mar. 2024 was 12.15.


Kenvue Cash Conversion Cycle Historical Data

The historical data trend for Kenvue's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kenvue Cash Conversion Cycle Chart

Kenvue Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
- 52.73 47.15 58.67 43.10

Kenvue Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.25 50.72 29.16 22.98 12.15

Competitive Comparison of Kenvue's Cash Conversion Cycle

For the Household & Personal Products subindustry, Kenvue's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kenvue's Cash Conversion Cycle Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Kenvue's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Kenvue's Cash Conversion Cycle falls into.



Kenvue Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Kenvue's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=49.57+109.4-115.87
=43.10

Kenvue's Cash Conversion Cycle for the quarter that ended in Mar. 2024 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=49.6+103.15-140.6
=12.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kenvue  (NYSE:KVUE) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Kenvue Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Kenvue's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Kenvue (Kenvue) Business Description

Traded in Other Exchanges
Address
199 Grandview Road, Skillman, NJ, USA, 08558
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Executives
Allison Richard E Jr director 30 FRANK LLOYD WRIGHT DR, ANN ARBOR MI 48105
Seemantini Godbole director 1000 LOWE'S BOULEVARD, MOORESVILLE NC 28117
Bing Xie officer: Group President, Asia Pacific 199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Donna Lorenson officer: Chief Corp Affairs Officer 199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Matthew Orlando officer: General Counsel 199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Luani Alvarado officer: Chief People Officer 199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Jan Meurer officer: Chief Growth Officer 199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Carlton Lawson officer: Group President, EMEA 199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Caroline Tillett officer: Chief Scientific Officer 199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Bernardo Tavares officer: Chief Tech & Data Officer 199 GRANDVIEW ROAD, SKILLMAN NJ 08558
Tamara Franklin director 107 STONE CLIFF ROAD, PRINCETON NJ 08540
Betsy D Holden director DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Kathy Widmer officer: Group President, NALA C/O ELIZABETH ARDEN, INC., 2400 S.W. 145 AVENUE, MIRAMAR FL 33027
Michael E Sneed director JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Joseph J Wolk director JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933

Kenvue (Kenvue) Headlines

From GuruFocus